These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28435061)

  • 61. Nanomedicine strategies for sustained, controlled, and targeted treatment of cancer stem cells of the digestive system.
    Xie FY; Xu WH; Yin C; Zhang GQ; Zhong YQ; Gao J
    World J Gastrointest Oncol; 2016 Oct; 8(10):735-744. PubMed ID: 27795813
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correlation between telomerase and mTOR pathway in cancer stem cells.
    Dogan F; Biray Avci C
    Gene; 2018 Jan; 641():235-239. PubMed ID: 29074462
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Targeting pancreatic cancer stem cells for cancer therapy.
    Xia J; Chen C; Chen Z; Miele L; Sarkar FH; Wang Z
    Biochim Biophys Acta; 2012 Dec; 1826(2):385-99. PubMed ID: 22728049
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Isolation, identification, and characterization of cancer stem cells: A review.
    Abbaszadegan MR; Bagheri V; Razavi MS; Momtazi AA; Sahebkar A; Gholamin M
    J Cell Physiol; 2017 Aug; 232(8):2008-2018. PubMed ID: 28019667
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic potential of cancer stem cells.
    Yang C; Jin K; Tong Y; Cho WC
    Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Nanoparticle-facilitated autophagy inhibition promotes the efficacy of chemotherapeutics against breast cancer stem cells.
    Sun R; Shen S; Zhang YJ; Xu CF; Cao ZT; Wen LP; Wang J
    Biomaterials; 2016 Oct; 103():44-55. PubMed ID: 27376558
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nanodrug-Mediated Thermotherapy of Cancer Stem-Like Cells.
    Rao W; Wang H; Zhong A; Yu J; Lu X; He X
    J Nanosci Nanotechnol; 2016 Mar; 16(3):2134-42. PubMed ID: 27455612
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.
    Shibuya K; Okada M; Suzuki S; Seino M; Seino S; Takeda H; Kitanaka C
    Oncotarget; 2015 Jan; 6(2):651-61. PubMed ID: 25528771
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Natural Products-Based Nanoformulations: A New Approach Targeting CSCs to Cancer Therapy.
    Liao W; Li Y; Wang J; Zhao M; Chen N; Zheng Q; Wan L; Mou Y; Tang J; Wang Z
    Int J Nanomedicine; 2022; 17():4163-4193. PubMed ID: 36134202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Nanomedicine strategies to counteract cancer stemness and chemoresistance.
    Liu H; Liu M; Zhao Y; Mo R
    Explor Target Antitumor Ther; 2023; 4(4):630-656. PubMed ID: 37720349
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cancer stem cells: the emerging challenge of drug targeting.
    Besançon R; Valsesia-Wittmann S; Puisieux A; Caron de Fromentel C; Maguer-Satta V
    Curr Med Chem; 2009; 16(4):394-416. PubMed ID: 19199913
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success.
    Desai A; Yan Y; Gerson SL
    Stem Cells Transl Med; 2019 Jan; 8(1):75-81. PubMed ID: 30328686
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cancer stem cells in relation to treatment.
    Miyoshi N; Mizushima T; Doki Y; Mori M
    Jpn J Clin Oncol; 2019 Mar; 49(3):232-237. PubMed ID: 30541049
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Extirpating the cancer stem cell hydra: Differentiation therapy and Hyperthermia therapy for targeting the cancer stem cell hierarchy.
    Tewari AB; Saini A; Sharma D
    Clin Exp Med; 2023 Nov; 23(7):3125-3145. PubMed ID: 37093450
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging nanomedicine-based strategies for preventing metastasis of pancreatic cancer.
    Li YJ; Wu JY; Wang JM; Xiang DX
    J Control Release; 2020 Apr; 320():105-111. PubMed ID: 31978441
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Biomaterials to suppress cancer stem cells and disrupt their tumoral niche.
    Garcia-Mazas C; Csaba N; Garcia-Fuentes M
    Int J Pharm; 2017 May; 523(2):490-505. PubMed ID: 27940172
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The potential of nanomedicine to alter cancer stem cell dynamics: the impact of extracellular vesicles.
    Gener P; Gonzalez Callejo P; Seras-Franzoso J; Andrade F; Rafael D; Abasolo I; Schwartz S
    Nanomedicine (Lond); 2020 Dec; 15(28):2785-2800. PubMed ID: 33191837
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cancer Stem Cells and Combination Therapies to Eradicate Them.
    Tang Q; Yin D; Wang Y; Du W; Qin Y; Ding A; Li H
    Curr Pharm Des; 2020; 26(17):1994-2008. PubMed ID: 32250222
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Heterogeneity of Tumors in Breast Cancer: Implications and Prospects for Prognosis and Therapeutics.
    Tuasha N; Petros B
    Scientifica (Cairo); 2020; 2020():4736091. PubMed ID: 33133722
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.